PMID- 22546392
OWN - NLM
STAT- MEDLINE
DCOM- 20120702
LR  - 20131121
IS  - 1527-9995 (Electronic)
IS  - 0090-4295 (Linking)
VI  - 79
IP  - 5
DP  - 2012 May
TI  - Comparison of harmful gases produced during GreenLight High-Performance System 
      laser prostatectomy and transurethral resection of the prostate.
PG  - 1118-24
LID - 10.1016/j.urology.2011.11.071 [doi]
AB  - OBJECTIVE: To compare the gases generated from GreenLight High-Performance System 
      (HPS) laser prostatectomy with Urosol or normal saline solution and transurethral 
      resection and vaporization of the prostate (TURVP) with Urosol. METHODS: A total 
      of 36 smoke samples were collected from a continuous irrigation suction system 
      attached to a Tenax absorber during transurethral surgery of the prostate. The 
      gases were qualitatively and quantitatively analyzed by gas chromatography-mass 
      spectrometry equipped with a purge and trap sample injector. RESULTS: The gas 
      produced during TURVP contained propylene, allene, isobutylene, 1,3-butadiene, 
      vinyl acetylene, mercaptomethane, ethyl acetylene, diacetylene, 1-pentene, 
      ethanol, piperylene, propenylacetylene, 1,4-pentadiene, cyclopentadiene, 
      acrylnitrile, and butyrolacton. The types and amount of gas produced during HPS 
      laser prostatectomy were fewer and smaller than during TURVP. However, 
      1,3-butadiene, a well-known human carcinogen, was also generated by HPS laser 
      prostatectomy. HPS laser prostatectomy with saline produced a greater amount and 
      number of gases than HPS laser prostatectomy with Urosol. CONCLUSION: The 
      surgical smoke produced from TURVP and HPS laser prostatectomy contains 
      potentially harmful chemical compounds, although HPS laser prostatectomy produced 
      less surgical smoke than TURVP. Urosol produced fewer types and a smaller amount 
      of gas than normal saline during HPS laser prostatectomy.
CI  - Copyright (c) 2012 Elsevier Inc. All rights reserved.
FAU - Park, Seung Chol
AU  - Park SC
AD  - Department of Urology, Wonkwang University School of Medicine and Hospital, 
      Iksan, Korea.
FAU - Lee, Sang Kyi
AU  - Lee SK
FAU - Han, Suk Hee
AU  - Han SH
FAU - Chung, Yun Jo
AU  - Chung YJ
FAU - Park, Jong Kwan
AU  - Park JK
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Urology
JT  - Urology
JID - 0366151
RN  - 0 (Alkenes)
RN  - 0 (Butadienes)
RN  - 0 (Cyclopentanes)
RN  - 0 (Gases)
RN  - 0 (Hazardous Substances)
RN  - 0 (Smoke)
RN  - 3K9958V90M (Ethanol)
RN  - JSD5FGP5VD (1,3-butadiene)
SB  - IM
CIN - Urology. 2012 May;79(5):1124-5; author reply 1125. PMID: 22546393
MH  - Aged
MH  - Alkenes/*analysis
MH  - Butadienes/analysis
MH  - Cyclopentanes/analysis
MH  - Ethanol/analysis
MH  - Gas Chromatography-Mass Spectrometry
MH  - Gases/*chemistry
MH  - Hazardous Substances/analysis
MH  - Humans
MH  - *Laser Therapy
MH  - Male
MH  - Middle Aged
MH  - Prospective Studies
MH  - Prostatectomy/*methods
MH  - *Smoke
MH  - *Transurethral Resection of Prostate
EDAT- 2012/05/02 06:00
MHDA- 2012/07/03 06:00
CRDT- 2012/05/02 06:00
PHST- 2011/10/19 00:00 [received]
PHST- 2011/11/29 00:00 [revised]
PHST- 2011/11/29 00:00 [accepted]
PHST- 2012/05/02 06:00 [entrez]
PHST- 2012/05/02 06:00 [pubmed]
PHST- 2012/07/03 06:00 [medline]
AID - S0090-4295(12)00100-8 [pii]
AID - 10.1016/j.urology.2011.11.071 [doi]
PST - ppublish
SO  - Urology. 2012 May;79(5):1118-24. doi: 10.1016/j.urology.2011.11.071.